https://ansm.sante.fr/actualites/reglement-europeen-relatif-aux-essais-cliniques-de-medicaments-fin-de-la-periode-de-transition

https://ansm.sante.fr/actualites/lansm-publie-son-rapport-dhemovigilance-de-lannee-2023

https://www.ema.europa.eu/en/news/meeting-highlights-pharmacovigilance-risk-assessment-committee-prac-28-31-october-2024

https://ansm.sante.fr/qui-sommes-nous/publications-institutionnelles/rapport-dactivite-2023/p/2023-en-bref#title

https://www.ema.europa.eu/en/news/meeting-highlights-pharmacovigilance-risk-assessment-committee-prac-2-5-september-2024

https://www.ema.europa.eu/en/news/harnessing-ai-medicines-regulation-use-large-language-models-llms